Stem cell therapy isnât some vague future concept. Itâs already used in South Africa for certain cancers, blood disorders, and rare conditions, but the question is whether medical aid covers any of it. Most schemes are either vague or exclude it. Some offer partial cover in very specific cases. The gap between science and paperwork can be wide.  This guide looks at which medical aids mention stem cell treatments at all, which procedures get flagged as âexperimentalâ, and what that means when you try to claim. Â
Can You Claim for Stem Cell Therapy Through Your Medical Aid?
Medical Aids in South Africa That Mention Stem Cell Therapies in Their Policies
Which Types of Stem Cell Procedures Are More Likely to Be Covered
How South African Medical Aids Define âExperimentalâ Treatments
Common Exclusions to Look For in Medical Aid Fine Print
Can You Claim for International Stem Cell Therapy with Local Medical Aid?
How to Check if Your Schemeâs Oncology or Chronic Benefits Include Stem Cell Use
 Â
Can You Claim for Stem Cell Therapy Through Your Medical Aid?
 Yes, you can claim for stem cell therapy through medical aid in South Africa, but only under certain conditions. It usually applies to transplants linked to certain cancers or blood disorders, not to broader uses that fall under experimental or unproven treatments.  Schemes that approve this type of treatment require it to match the Prescribed Minimum Benefit criteria. This includes conditions such as leukaemia, lymphoma, and severe immune or metabolic disorders.  If the treatment forms part of the recognised protocol for one of these, and your plan includes hospital or oncology benefits, it is typically fully funded. Some policies will only cover it if it's classified under PMB, regardless of your benefit level.  The treatment must be clinically appropriate for your diagnosis. The scheme will ask for documentation from your treating specialist, and authorisation depends on medical review. Â
Medical Aids in South Africa That Mention Stem Cell Therapies in Their Policies
 Some of the bigger South African medical aids cover stem cell treatment, but only where the clinical use matches national treatment guidelines. This almost always means haemopoietic (bone marrow) stem cell transplants for severe blood-related conditions. Apart from that, thereâs nothing.  Here are the top 3 South African medical aids and their coverage in terms of stem cell therapies. Â
Discovery Health
 Discovery funds bone marrow stem cell transplants across all plans, but only when the diagnosis matches specific PMB conditions. These usually involve blood cancers or bone marrow failure.  Â
  Â
Covers haemopoietic stem cell transplants linked to the Prescribed Minimum Benefits.
All plan levels include this cover, from KeyCare up to Executive.
You must get pre-authorisation and follow the approved treatment path.
Treatment must take place at a designated provider, or co-payments apply.
Supportive treatments linked to the transplant are included, if clinically approved.
 Umbilical cord stem cell storage is available through Netcells, but entirely self-funded. Â
Medshield
 Medshield offers cover for bone marrow transplants under its hospital benefits, but only within strict parameters.  Â
  Â
Covers both autologous and donor transplants, but only for PMB-approved diagnoses.
Compact Network hospitals must be used to avoid a 30% co-payment.
No support for international donor searches or matching services.
Funding only applies if the transplant is clinically necessary and approved beforehand.
 Elective or regenerative therapies fall outside the schemeâs benefits. Â
Bankmed
 Bankmed includes haemopoietic stem cell transplants under its main transplant benefit.  Â
  Â
Applies across all plan levels without a separate benefit tier.
Covers both self-donated and matched donor grafts if authorised.
Hospital costs, specialist care, and transplant-related medication are included.
Pre-authorisation is mandatory and must follow internal guidelines.
Experimental treatments and regenerative procedures are excluded outright.
 No provision for international sourcing or cord blood storage. Â
Which Types of Stem Cell Procedures Are More Likely to Be Covered
 Some stem cell treatments are medically recognised in South Africa, particularly where they are used to treat blood cancers or severe immune conditions.  These procedures are more likely to be covered by medical aid because they are included under the Prescribed Minimum Benefits (PMBs). Medical schemes must fund PMBs, regardless of the benefit option, if the diagnosis and treatment meet the clinical criteria.  Other stem cell uses, like regenerative therapies or elective procedures, are not recognised as part of standard treatment protocols. These are usually excluded on the basis that they are experimental, unproven, or outside the scope of local clinical guidelines.  The table below outlines the types of stem cell procedures most likely to receive funding from South African medical aids, and where cover is typically denied. Â
đ Stem cell procedure
âŞď¸ Coverage likelihood
âĄď¸ Conditions and notes
Autologous
haematopoietic stem cell
transplant
High
Used for multiple
myeloma and
lymphoma.
Recognised under
PMB. Requires
specialist referral
Allogeneic (related or
unrelated) transplant
High
Accepted for
leukaemia and
lymphomas. Donor
search is often
included. PMB applies
Umbilical cord blood
transplant
High for PMB-listed
conditions
Used as an alternative
to bone marrow. Must
be matched and
preauthorised
Donor search, harvesting,
and transplant costs
High but subject to
tariff limits
Included under
transplant benefits for
recognised diagnoses.
Preauthorisation
required
Peripheral blood stem
cell harvest (autologous)
Mid to high
Often used in cancer
protocols. May be
included as part of
transplant funding
Cord blood banking
(private)
None
Treated as a personal
expense. Not funded
by schemes.
Mesenchymal or
regenerative stem cell
injections
Very low or no
Regarded as
experimental. Excluded
from benefits
Experimental autologous
procedures (non-PMB)
None
Not covered unless
treatment is proven
and supported by local
clinical guidelines
International stem cell
therapy is not aligned to
PMB
None
Excluded unless it
qualifies as a PMB and
is approved by the
scheme in advance
 The key to accessing stem cell cover through medical aid is alignment with PMB rules. Any treatment that falls outside those definitions is almost always rejected by default. For anything beyond transplant-related care, youâll need to self-fund or explore medical loans. Â
How South African Medical Aids Define âExperimentalâ Treatments
Medical aids in South Africa exclude any treatment they classify as experimental, including stem cell therapies that havenât been accepted in formal treatment protocols or backed by long-term clinical evidence. The label isnât based on how new something is, but on whether it meets precise criteria. Â Each scheme word this differently, but they all follow the same logic. If a treatment hasnât been proven effective for your condition in peer-reviewed research, or if local health regulators havenât approved it, it wonât be funded. Medical aids usually call a treatment âexperimentalâ when:Â Â
It is still in the testing or trial phase and not part of standard medical practice.
Thereâs no official approval from SAHPRA or professional guidelines from the HPCSA.
It isnât included in the treatment protocols used by South African specialists.
No long-term outcomes have been published in peer-reviewed clinical studies.
It is used in a way that isnât supported by your diagnosis or care plan.
It is offered outside formal medical networks or through private wellness clinics.
The medication or material used is not registered for use in South Africa.
 It is promoted for pain, ageing, immune support, or general health without clinical backing. Â
Common Exclusions to Look For in Medical Aid Fine Print
 Apart from experimental treatment, here are other exclusions that you need to know about in terms of stem cell therapy: Â
đ Exclusion
âŞď¸ Why is it excluded
Stem cell therapy for
non-PMB conditions
Not part of mandatory
benefits and often
considered
investigational
Preventative stem cell
banking
Seen as future
planning, not
medically necessary at
the time of collection
Regenerative or cosmetic
stem cell use
No recognised clinical
guideline or formal
diagnosis is driving the
treatment
Overseas stem cell
therapy
Not approved under
SAHPRA and not
aligned to local
treatment protocols
Unregistered
medications or
biologics
Schemes only fund
products legally
registered for use in
South Africa
Unapproved clinical trial
participation
Trials are not covered
unless part of a
registered SA-based
programme
Wellness and anti-ageing
treatments
These are not linked to
any medical diagnosis
or prescribed care
pathway
Storage fees for stem
cells
Considered a lifestyle
or elective cost, not a
medical necessity
Non-network provider
claims
If the treatment or
provider falls outside
the planâs approved
networks or facilities
 Â
Can You Claim for International Stem Cell Therapy with Local Medical Aid?
 Yes, you can claim for international stem cell therapy under your South African medical aid. However, it meets strict criteria: it must be clinically justified as a PMB and follow recognised treatment pathways. Nonâstandard therapies overseas wonât qualify automatically. To see if you qualify: Â
Confirm your condition is listed under the PMB rules that cover overseas treatment.
Check that overseas treatment matches approved clinical protocols recognised locally.
Obtain pre-authorisation and ensure the scheme accepts the overseas provider.
 Understand reimbursement rules (often capped at local rates or a limit per year). Â
How to Check if Your Schemeâs Oncology or Chronic Benefits Include Stem Cell Use
 The exact process will depend on your scheme, plan, and benefits, but hereâs a general guideline on how to check whether your medical aid oncology or chronic benefit includes stem cell use: Â
Read your benefit guide or plan summary. Look for keywords like âbone marrow transplantâ, âhaematopoietic stem cell transplantâ, or âstem cell supportâ.
Check the chronic and oncology disease lists. Confirm whether your diagnosis qualifies for PMB cover or chronic condition support. The Council for Medical Schemes publishes these and applies them to all medical aids in South Africa.
Review treatment protocols in the plan documents. These show which procedures are supported for each condition.
Identify whether your scheme uses designated service providers. Some plans limit funding to specific hospitals, specialists, or registries.
Confirm if pre-authorisation is required. Most schemes wonât fund stem cell treatment unless approval is given in writing ahead of time.
Ask about annual limits. Some schemes have yearly limits on oncology cover or transplant-related treatment. Stem
If your condition isnât cancer-related, check the chronic illness benefit. Some autoimmune or genetic conditions may qualify for stem cell use under chronic benefits, but this depends on diagnosis, treatment type, and whether the therapy is accepted locally.
 Request clinical funding criteria directly from your scheme. Youâre entitled to ask for the medical guidelines they use to approve or decline stem cell therapy, especially under chronic or oncology benefits. Â
 Â
In Conclusion
 Â
  Stem cell therapy is available in South Africa, but medical aid cover is limited to specific conditions and recognised treatment plans. Most schemes will only approve it when the treatment qualifies under PMB rules and follows the clinical guidelines tied to a formal diagnosis.  Before starting anything, read your plan documents, speak to your specialist, and get written confirmation from your scheme. Stem cell therapy can be life-saving in the right context, but medical aids donât cover broad or unproven uses.  You might also like: Â